Stay updated with the latest biopharmaceutical news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on biopharmaceutical topics.
Mumbai, Apr 6 (PTI) India's healthcare and pharmaceutical sector is set to enter a capability-led growth phase, potentially creating 2 to 2.5 million new jobs by 2030, while 30 to 35 per cent of the workforce will likely need reskilling, according to a report released on Monday. The country's healthcare and pharmaceutical sector is moving into a capability-led growth phase, with hiring increasingly focused on specialisation and technology integration across hospitals, AYUSH, home and elder care ...Read More >
Hyderabad, April 6 (RAHNUMA): CuraTeQ Biologics, a subsidiary of Aurobindo Pharma, has announced positive top-line results from its Phase 3 trial of BP11, an investigational biosimilar to Omalizumab (marketed as Xolair). The study met all primary endpoints, demonstrating strong comparability with the reference drug in treating chronic spontaneous urticaria (CSU) at a 300 mg dose. Conducted across 608 patients at nearly 80 sites in Europe and India, the trial showed precise equivalence in itch s ...Read More >
Hyderabad, April 4 (RAHNUMA): The Government of India reaffirmed strong support for the pharmaceutical sector at a high-level Chintan Shivir organized by the Department of Commerce and Pharmexcil. The inaugural session was chaired by Rajesh Agrawal, Secretary, Department of Commerce. Senior officials including the Chairman of Pharmexcil and Joint Secretary from the Department of Pharmaceuticals addressed the gathering. The Commerce Secretary, in his address, highlighted the strong growth traje ...Read More >
Hyderabad: The Chintan Shivir on the Pharmaceutical Sector, organized by the Pharmaceutical Export Promotion Council of India (PHARMEXCIL), with the support of the Ministry of Commerce & Industry, Government of India, concluded successfully today in Hyderabad. This event marked the continuation of the series of discussions, following successful editions in Chandigarh and Ahmedabad, and served as a platform for strengthening India's pharmaceutical export agenda. The inaugural session, chaired by ...Read More >
New Delhi, April 5 (SocialNews.XYZ) India's pharmaceutical exports reached over $28 billion up to February in the current financial year, registering a growth of more than 5 per cent compared to the same period last year, a senior government official has said. Speaking at the inaugural session of the 'Chintan Shivir: Scaling Up Pharma Exports', the official highlighted that the growth was led by formulations, biologicals, vaccines, and Ayush products. "Despite global challenges, pharmaceutical ...Read More >
HYDERABAD: India's pharmaceutical exports touched nearly USD 28.29 billion by February this financial year, marking a 5.6% growth compared to last year, a top official said at the Chintan Shivir-Scaling up Pharma Exports programme held in Hyderabad on Saturday. Organised by the Pharmaceutical Export Promotion Council of India (Pharmexcil) with support from the Union government, the event was chaired by commerce secretary Rajesh Agarwal, who said India's pharmaceutical industry, valued at around ...Read More >
Hyderabad: India's pharma exports are likely to miss the FY26 target of $32 billion because of the West Asia crisis, though they should still exceed FY25 exports of $30.47 billion, Pharmexcil chairman Namit Joshi said at the Pharmexcil Chintan Shivir in Hyderabad.Joshi said the industry had invoiced a record $1.6 billion of exports to the US in March 2025, ahead of US tariffs that took effect in April 2025, compared with the usual monthly average of about $800 million. But in March 2026, the ind ...Read More >
New Delhi: Commerce secretary Rajesh Agrawal Saturday asked the pharmaceutical industry to reduce its dependence on critical imported raw materials by meeting atleast 80-90% of domestic pharmaceutical requirements through indigenous production. Addressing an event in Hyderabad, he said while India exports to around 200 countries, there remains significant scope for expansion and resilience-building through a stronger market presence. Emphasising the need to navigate an increasingly uncertain a ...Read More >
Striking a cautiously optimistic note, a senior official in the Commerce Ministry and representatives of the Pharmaceuticals Export Promotion Council of India on Saturday said FY26 pharma exports are expected to remain in the positive zone notwithstanding the West Asia war's impact on the March performance. For the 11 months upto February, the exports were nearly $28.29 billion as against the $26.79 billion in the corresponding period of previous fiscal. "We have already achieved 5.6% growth up ...Read More >
New Delhi: The government is working to ensure minimal disruption to supply chains amid global uncertainties, while remaining prepared for a potential dip in exports and imports, Commerce Secretary Rajesh Agrawal said on Saturday. Addressing the press conference on the sidelines of a 'Chintan Shivir' session in Hyderabad, Agrawal told the media that the initiative aims to bring together government and industry stakeholders to identify challenges and chart a clear roadmap. The official also sta ...Read More >
Hyderabad: India's pharmaceutical exports stood at over USD 28 billion up to February in the last financial year, registering a growth of more than 5 per cent compared to the same period last year, a top official said on Saturday. K Raja Bhanu, Director General of the Pharmaceuticals Export Promotion Council of India (Pharmexcil), said the sector, currently valued at around USD 60 billion, is projected to grow to USD 130 billion by 2030. "Despite global challenges, pharmaceutical exports have ...Read More >
New Delhi, Apr 4 (PTI) Commerce Secretary Rajesh Agrawal on Saturday asked the pharmaceutical industry to reduce its dependence on critical imported raw materials and diversify export supply chains to better navigate global uncertainties. Addressing an event in Hyderabad on the sector, he said while India exports to around 200 countries, there remains significant scope for expansion and resilience-building through a stronger market presence. Emphasising the need to navigate an increasingly unc ...Read More >
Hyderabad, Apr 4 (PTI) India's pharmaceutical exports stood at over USD 28 billion up to February of the current financial year, registering a growth of more than 5 per cent compared to the same period last year, a top official said on Saturday. K Raja Bhanu, Director General of the Pharmaceuticals Export Promotion Council of India (Pharmexcil), said the sector, currently valued at around USD 60 billion, is projected to grow to USD 130 billion by 2030. "Despite global challenges, pharmaceutica ...Read More >
Hyderabad, Apr 4 (PTI) Indian pharmaceutical exports stood at nearly USD 29 billion up to February this financial year registering a growth of five per cent compared to the same period last year, a top official said on Saturday. K Raja Bhanu, Director General, Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) said the sector, currently valued at approximately USD 60 billion, is projected to grow to USD 130 billion by 2030. "Inspite of global challenges, pharmaceuticals exports hav ...Read More >
India's biotech ecosystem has also expanded significantly, now comprising over 2,500 startups, around 100 incubators, more than 600 research institutes, and over 200 accredited laboratories India's biotech sector is entering a new phase of global relevance, with the country's bioeconomy expanding from $10 billion in 2014 to $195 billion in 2026 and projected to touch nearly $300 billion by 2033, according to a report by Endiya Partners. The report, India's Biopharma Moment: Perspectives from D ...Read More >
New Delhi, March 31 (SocialNews.XYZ) India's bioeconomy is approaching the $200 billion mark, which is a significant milestone in its evolution with a strong policy push and growing innovation pipeline signalling the next phase of growth, according to a report released on Tuesday. The report by Endiya Partners said that the nation's bioeconomy has expanded sharply from around $10 billion in 2014 to over $195 billion in 2026, now contributing nearly 5 per cent to the GDP. India, long recognised ...Read More >
New Delhi, Dec 17 (PTI) Biopharmaceutical firm Bristol Myers Squibb (BMS) and IT services company Accenture on Wednesday announced the opening of a new AI-powered content hub, Mosaic, in Mumbai. The generative AI-enabled facility is designed to accelerate BMS's global commercialisation strategy through enhanced digital capabilities, enabling the rapid creation of hyper-personalised, patient-centric content tailored for healthcare professionals, according to a joint statement. The launch of Mos ...Read More >
New Delhi, Dec 17 (PTI) Biopharmaceutical firm Bristol Myers Squibb (BMS) and IT services company Accenture on Wednesday announced the opening of a new AI-powered content hub, Mosaic, in Mumbai. The generative AI-enabled facility is designed to accelerate BMS's global commercialisation strategy through enhanced digital capabilities, enabling the rapid creation of hyper-personalised, patient-centric content tailored for healthcare professionals, according to a joint statement. The launch of Mos ...Read More >
Bhubaneswar: The Odisha government Tuesday unveiled Pharmaceutical and Medical Devices Policy-2025, aiming to attract investment of Rs 25,000 crore and create 1 lakh jobs by 2030. Chief Minister Mohan Charan Majhi launched the new policy here at the Odisha Pharma Summit-2025 in the presence of Industries Minister Sampad Chandra Swain and senior government officers. Speaking on the occasion, Industries Department's Additional Chief Secretary Hemant Sharma said India imports about 85 per cent of ...Read More >
Mumbai, Oct 31 (SocialNews.XYZ) Actress Deepika Padukone, who has been a strong advocate for mental health awareness, reacted to cricketer Jemimah Rodrigues' recent revelation about battling anxiety. The 'Om Shanti Om' actress, known for openly sharing her own struggles with depression in the past, praised Jemimah for her honesty and courage in speaking up, highlighting the importance of conversations around mental well-being in sports and beyond. Taking to her Instagram Stories, Deepika Paduko ...Read More >
New Delhi [India], October 31 (ANI): The U.S. Food and Drug Administration (FDA) has announced major steps to make it faster and less costly to develop biosimilar medicines, lower-cost "generic" alternatives to biologic drugs used to treat serious and chronic diseases. In a new draft guidance, the FDA has proposed major updates aimed at simplifying biosimilarity studies and reducing unnecessary clinical testing. The agency also launched a separate initiative to make it easier for biosimilars t ...Read More >
The information was shared by Union Minister Jitendra Singh, who said the antibiotic is the first molecule entirely conceptualised, developed and clinically validated in India. The antibiotic, Naphithromycin, has been developed by the Department of Biotechnology in collaboration with private pharma house Wockhardt. Citing this as an example of successful industry-academia partnership driving India's biopharmaceutical growth, the Union Minister emphasised the need to build a self-sustainable in ...Read More >
The Indian Pharmaceutical Alliance (IPA) has appointed Sharvil Patel of Zydus Lifesciences as its new President, with Glenn Saldanha of Glenmark as Vice President. This leadership transition occurs as the industry navigates GST reforms and strengthens its global position in specialty medicines. The new team aims to drive innovation, patient access, and quality healthcare solutions. The Indian Pharmaceutical Alliance (IPA) has appointed Sharvil Patel, Managing Director of Zydus Lifesciences as i ...Read More >
Mumbai, Aug 14 (SocialNews.XYZ) AstraZeneca Pharma India Limited on Thursday reported a 4.12 per cent decline in net profit for the first quarter (Q1) of FY26, with earnings falling to Rs 55.8 crore from Rs 58.2 crore in the previous quarter (Q4 FY25). This dip came despite a strong rise in revenue from operations, which grew 9.56 per cent sequentially to Rs 526.3 crore from Rs 480.4 crore, according to its stock exchange filing. Other income saw a sharp decline of 30.43 per cent, dropping to ...Read More >
SCHOTT, a leader in specialty glass, initiates local production of high-precision glass tubing for syringes and cartridges in Gujarat, India. This marks a significant step in India's pharmaceutical sector, aligning with the 'Make in India' initiative, enhancing SCHOTT's role in the Asian market. In a notable development in India's pharmaceutical landscape, SCHOTT has successfully commenced local production of high-precision glass tubing for syringes and cartridges at its Jambusar, Gujarat facil ...Read More >
New Delhi, Aug 12 (PTI) Drug firm Lupin on Tuesday said it has partnered with Switzerland-based Sandoz Group AG to commercialise its biosimilar ranibizumab across multiple regions. Under the terms of the agreement, Sandoz will oversee commercialisation of the product across the European Union (excluding Germany), Switzerland, Norway, Australia, Hong Kong, Vietnam, and Malaysia, the Mumbai-based drug maker said in a statement. Lupin will be responsible for manufacturing the product and for regu ...Read More >
Reshma Kewalramani was appointed CEO of Vertex Pharmaceuticals in April 2020 ShowQuick Read Summary is AI-generated, newsroom-reviewed * Reshma Kewalramani ranks 62 on Fortune's 2025 list of 100 Most Powerful People in Business * She is the first woman to lead a major US biotechnology firm, Vertex Pharmaceuticals * Vertex is valued at over $110 billion, known for cystic fibrosis and gene-editing therapies Did our AI summary help? Let us know. Switch To Beeps Mode Indian-origin CEO Reshm ...Read More >
Bengaluru, Jul 8 (PTI) Just in 2024 alone, respiratory syncytial virus (RSV) claimed 2,360 lives of children in hospitals notified in Bengaluru, Kolkata and Mumbai, said Dr Vasant M Khalatkar, National President of the Indian Academy of Pediatrics (IAP) on Tuesday. Yet, RSV, often mistaken for a mild seasonal cold, is an under-discussed cause of lower respiratory tract infections in infants and children under five, he added. According to Dr Khalatkar, the 2024 data is just the tip of the ice-b ...Read More >
Bengaluru: Karnataka chief minister Siddaramaiah's comments suggesting Covid-19 vaccination may have caused the recent heart-attack related deaths in the state's Hassan district has triggered a wave of rebuttals from senior doctors, Biocon founder Kiran Mazumdar-Shaw and the BJP. The All India Institute of Medical Sciences dismissed any connection between the two. A study on the people who succumbed to sudden cardiac arrests did not reveal any link to the Covid vaccination, said Karan Madan, as ...Read More >
New Delhi, Jun 27 (PTI) Biocon Ltd on Friday said its arm Biocon Biologics has been granted a notice of compliance by Health Canada for its biosimilar Yesafili injection used to treat various ailments of the eye. "Health Canada has granted a Notice of Compliance (NOC) for Yesafili(aflibercept), a biosimilar to Eylea injection, in vial and prefilled syringe presentations, 2 mg/0.05 mL on June 26, 2025," a regulatory filing by Biocon said. This approval paves the way for the launch of Yesafili i ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.